These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22844497)

  • 61. Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa.
    Augustin DK; Song Y; Baek MS; Sawa Y; Singh G; Taylor B; Rubio-Mills A; Flanagan JL; Wiener-Kronish JP; Lynch SV
    J Bacteriol; 2007 Mar; 189(6):2203-9. PubMed ID: 17209027
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficient isolation of Pseudomonas aeruginosa type III secretion translocators and assembly of heteromeric transmembrane pores in model membranes.
    Romano FB; Rossi KC; Savva CG; Holzenburg A; Clerico EM; Heuck AP
    Biochemistry; 2011 Aug; 50(33):7117-31. PubMed ID: 21770428
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An epoxide hydrolase secreted by Pseudomonas aeruginosa decreases mucociliary transport and hinders bacterial clearance from the lung.
    Hvorecny KL; Dolben E; Moreau-Marquis S; Hampton TH; Shabaneh TB; Flitter BA; Bahl CD; Bomberger JM; Levy BD; Stanton BA; Hogan DA; Madden DR
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L150-L156. PubMed ID: 28982736
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modulation of the immune response by the
    Jouault A; Saliba AM; Touqui L
    Front Cell Infect Microbiol; 2022; 12():1064010. PubMed ID: 36519135
    [No Abstract]   [Full Text] [Related]  

  • 65. Differential ASC requirements reveal a key role for neutrophils and a noncanonical IL-1β response to Pseudomonas aeruginosa.
    Patankar YR; Mabaera R; Berwin B
    Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L902-13. PubMed ID: 26472815
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Current fluctuation analysis of the PopB and PopD translocon components of the Pseudomonas aeruginosa type III secretion system.
    Wager B; Faudry E; Wills T; Attree I; Delcour AH
    Biophys J; 2013 Apr; 104(7):1445-55. PubMed ID: 23561521
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response.
    Kwuan L; Adams W; Auerbuch V
    Infect Immun; 2013 Mar; 81(3):905-14. PubMed ID: 23297383
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The human NAIP-NLRC4-inflammasome senses the Pseudomonas aeruginosa T3SS inner-rod protein.
    Grandjean T; Boucher A; Thepaut M; Monlezun L; Guery B; Faudry E; Kipnis E; Dessein R
    Int Immunol; 2017 Aug; 29(8):377-384. PubMed ID: 28992059
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In the absence of effector proteins, the Pseudomonas aeruginosa type three secretion system needle tip complex contributes to lung injury and systemic inflammatory responses.
    Audia JP; Lindsey AS; Housley NA; Ochoa CR; Zhou C; Toba M; Oka M; Annamdevula NS; Fitzgerald MS; Frank DW; Alvarez DF
    PLoS One; 2013; 8(11):e81792. PubMed ID: 24312357
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Psychrotrophic Pseudomonas lundensis, a Non-
    Ravi K; Falkowski NR; Scales BS; Akulava VD; Valentovich LN; Huffnagle GB
    mBio; 2022 Feb; 13(1):e0386921. PubMed ID: 35189702
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cytosolic phospholipase A2α enhances mouse mortality induced by Pseudomonas aeruginosa pulmonary infection via interleukin 6.
    Guillemot L; Medina M; Pernet E; Leduc D; Chignard M; Touqui L; Wu Y
    Biochimie; 2014 Dec; 107 Pt A():95-104. PubMed ID: 25201511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.
    Ader F; Le Berre R; Faure K; Gosset P; Epaulard O; Toussaint B; Polack B; Nowak E; Viget NB; Kipnis E; Guery BP
    Infect Immun; 2005 Jul; 73(7):4263-71. PubMed ID: 15972518
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pseudomonas aeruginosa Magnesium Transporter MgtE Inhibits Type III Secretion System Gene Expression by Stimulating
    Chakravarty S; Melton CN; Bailin A; Yahr TL; Anderson GG
    J Bacteriol; 2017 Dec; 199(23):. PubMed ID: 28847924
    [No Abstract]   [Full Text] [Related]  

  • 74. Glutathione Activates Type III Secretion System Through Vfr in
    Zhang Y; Zhang C; Du X; Zhou Y; Kong W; Lau GW; Chen G; Kohli GS; Yang L; Wang T; Liang H
    Front Cell Infect Microbiol; 2019; 9():164. PubMed ID: 31157178
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.
    Le Berre R; Nguyen S; Nowak E; Kipnis E; Pierre M; Quenee L; Ader F; Lancel S; Courcol R; Guery BP; Faure K;
    Crit Care Med; 2011 Sep; 39(9):2113-20. PubMed ID: 21572326
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ablation of PDE4B protects from Pseudomonas aeruginosa-induced acute lung injury in mice by ameliorating the cytostorm and associated hypothermia.
    Abou Saleh L; Boyd A; Aragon IV; Koloteva A; Spadafora D; Mneimneh W; Barrington RA; Richter W
    FASEB J; 2021 Sep; 35(9):e21797. PubMed ID: 34383981
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hypoxia Reduces the Pathogenicity of Pseudomonas aeruginosa by Decreasing the Expression of Multiple Virulence Factors.
    Schaible B; Rodriguez J; Garcia A; von Kriegsheim A; McClean S; Hickey C; Keogh CE; Brown E; Schaffer K; Broquet A; Taylor CT
    J Infect Dis; 2017 May; 215(9):1459-1467. PubMed ID: 28368464
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation.
    Anantharajah A; Faure E; Buyck JM; Sundin C; Lindmark T; Mecsas J; Yahr TL; Tulkens PM; Mingeot-Leclercq MP; Guery B; Van Bambeke F
    J Infect Dis; 2016 Oct; 214(7):1105-16. PubMed ID: 27412581
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fructooligosacharides reduce Pseudomonas aeruginosa PAO1 pathogenicity through distinct mechanisms.
    Ortega-González M; Sánchez de Medina F; Molina-Santiago C; López-Posadas R; Pacheco D; Krell T; Martínez-Augustin O; Abdelali D
    PLoS One; 2014; 9(1):e85772. PubMed ID: 24465697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.